Acarbose is indicated for:
Population group: both men and women, only adults (18 years old or older)
Acarbose is recommended for the treatment of non-insulin dependent (NIDDM) diabetes mellitus in patients inadequately controlled on diet alone, or on diet and oral hypoglycaemic agents.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Acarbose is contraindicated in the following cases: